RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Fampridine Prolonged Release Improves Walking Ability and Balance in Patients with Multiple Sclerosis
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 6
SP 12
OP 13
DO 10.1177/155989771406008
UL http://mdc.sagepub.com/content/14/6/12.abstract
AB Treatment with prolonged-release fampridine results in sustained, clinically meaningful improvement in walking ability and balance in patients with multiple sclerosis (MS). This article presents the results of Exploratory Study to Assess the Effect of Fampridine on Walking Ability and Balance in Patients With Multiple Sclerosis (MOBILE; NCT01597297), an exploratory, phase 2, randomized, double-blinded, placebo-controlled trial.